肝癌介入治疗后心脏并发症的预防及治疗

目的：探讨肝癌介入治疗后心脏并发症发生的原因及预防，处理措施，方法：原发性肝癌病人4例，年龄36－65岁，所有病人接受经导管肝动脉化疗栓塞（TAE）治疗，术后进行心电监护，心电图检查和心肌酶谱（HEA）检查。结果：4例病人均有心前区不适感，T波轻度改变，心型肌酸激酶（CK－MB）升高，提示有心肌受损现象，经治疗后，3例治愈出院，1例因多器官功能衰竭死亡，结论：肝癌介入治疗后心脏并发症是一种少见的并发症，如能早期发现，并及时处理，病人一般能康复。

Prevention and treatment of the cardiac complication in the patients with primary hepatocellular carcinoma after interventional therapy

Objective:To investigate the causes of cardiac complication and method of prevention and treatment in the patients with primary hepatocellular carcinoma (HCC) after interventional therapy.Methods:4 cases of HCC,aged from 36 to 65 yrs,were followed up continuous electrocardiogram monitoring,and examinations of electrocardiogram and HEA after TAE.Results:Precordial fullness,the anomaly of T wave on electrocardiogram and elevation of CK MB in 4 cases indicated the damage of myocardium.After therapy,3 cases were healed to discharge from hospital and one died of several organ failure.Conclusion:The cardiac complications in the patients with HCC after interventional therapy are uncommon and the patients will get over if the complication is detected early and managed simultaneously .